APOA1 and type 2 diabetes mellitus: TyG Triglyceride–glucose index, BMI Body mass index, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, ApoA1 Apolipoprotein A1 ApoB Apolipoprotein B, HbA1c Glycated hemoglobin, HOMA-IR Homeostatic model assessment of insulin resistance, WBC White blood cell count, hs-CRP High-sensitivity C-reactive protein, eGFR Estimated glomerular filtration rate, ALT Alanine aminotransferase, AST Aspartate aminotransferase, MACE Major adverse cardiovascular events, T2D Type 2 diabetes.